JP2008521440A5 - - Google Patents

Download PDF

Info

Publication number
JP2008521440A5
JP2008521440A5 JP2007544479A JP2007544479A JP2008521440A5 JP 2008521440 A5 JP2008521440 A5 JP 2008521440A5 JP 2007544479 A JP2007544479 A JP 2007544479A JP 2007544479 A JP2007544479 A JP 2007544479A JP 2008521440 A5 JP2008521440 A5 JP 2008521440A5
Authority
JP
Japan
Prior art keywords
seq
amino acid
xaa
acid sequence
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007544479A
Other languages
English (en)
Japanese (ja)
Other versions
JP5039560B2 (ja
JP2008521440A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/043373 external-priority patent/WO2006060513A2/en
Publication of JP2008521440A publication Critical patent/JP2008521440A/ja
Publication of JP2008521440A5 publication Critical patent/JP2008521440A5/ja
Application granted granted Critical
Publication of JP5039560B2 publication Critical patent/JP5039560B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2007544479A 2004-11-30 2005-11-30 Toll様受容体3アンタゴニスト、方法および使用 Expired - Fee Related JP5039560B2 (ja)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US63181504P 2004-11-30 2004-11-30
US60/631,815 2004-11-30
US63639904P 2004-12-15 2004-12-15
US60/636,399 2004-12-15
US64187705P 2005-01-06 2005-01-06
US60/641,877 2005-01-06
US71319505P 2005-08-31 2005-08-31
US60/713,195 2005-08-31
US72761005P 2005-10-18 2005-10-18
US60/727,610 2005-10-18
PCT/US2005/043373 WO2006060513A2 (en) 2004-11-30 2005-11-30 Toll like receptor 3 antagonists, methods and uses

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2012097822A Division JP2012149092A (ja) 2004-11-30 2012-04-23 Toll様受容体3アンタゴニスト、方法および使用

Publications (3)

Publication Number Publication Date
JP2008521440A JP2008521440A (ja) 2008-06-26
JP2008521440A5 true JP2008521440A5 (cg-RX-API-DMAC7.html) 2009-01-22
JP5039560B2 JP5039560B2 (ja) 2012-10-03

Family

ID=36565702

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2007544479A Expired - Fee Related JP5039560B2 (ja) 2004-11-30 2005-11-30 Toll様受容体3アンタゴニスト、方法および使用
JP2012097822A Pending JP2012149092A (ja) 2004-11-30 2012-04-23 Toll様受容体3アンタゴニスト、方法および使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2012097822A Pending JP2012149092A (ja) 2004-11-30 2012-04-23 Toll様受容体3アンタゴニスト、方法および使用

Country Status (15)

Country Link
US (1) US8153583B2 (cg-RX-API-DMAC7.html)
EP (2) EP1824514B1 (cg-RX-API-DMAC7.html)
JP (2) JP5039560B2 (cg-RX-API-DMAC7.html)
KR (1) KR101317264B1 (cg-RX-API-DMAC7.html)
AR (1) AR051836A1 (cg-RX-API-DMAC7.html)
AU (1) AU2005311894A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0518664A2 (cg-RX-API-DMAC7.html)
CA (1) CA2589636C (cg-RX-API-DMAC7.html)
EA (1) EA200701192A1 (cg-RX-API-DMAC7.html)
IL (1) IL183541A (cg-RX-API-DMAC7.html)
MX (1) MX2007006442A (cg-RX-API-DMAC7.html)
NO (1) NO20073293L (cg-RX-API-DMAC7.html)
NZ (1) NZ555475A (cg-RX-API-DMAC7.html)
TW (1) TWI487535B (cg-RX-API-DMAC7.html)
WO (1) WO2006060513A2 (cg-RX-API-DMAC7.html)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0121591D0 (en) 2001-09-06 2001-10-24 Chiron Spa Hybrid and tandem expression of neisserial proteins
ES2435775T3 (es) * 2005-10-27 2013-12-23 Janssen Biotech, Inc. Moduladores de receptor tipo Toll 3, procedimientos y usos
US8066981B2 (en) * 2006-11-14 2011-11-29 The Texas A & M University System Compositions and methods related to toll-like receptor-3
EP2155889A4 (en) * 2007-05-25 2010-06-16 Centocor Ortho Biotech Inc TOLL RECEPTOR 3 MODULATORS AND USES THEREOF
SI2796466T1 (en) 2007-12-07 2018-01-31 Zymogenetics, Inc. Molecules of Humanized Specifics Specifiable for IL-31
AU2008345179A1 (en) * 2007-12-26 2009-07-09 Centocor, Inc. Cynomolgus toll-like receptor 3
EP2294085A1 (en) * 2008-06-09 2011-03-16 Novartis AG Antibodies against neisserial factor h binding protein
DE602008004898D1 (de) * 2008-06-27 2011-03-24 Theranor Sprl Pharmazeutische Zusammensetzungen von Antikörpern von Viruserkrankungen
US8895263B2 (en) * 2008-10-02 2014-11-25 Janssen Biotech, Inc. Methods for suppressing toll-like receptor activity
US8460659B2 (en) 2008-10-31 2013-06-11 Janssen Biotech, Inc. Toll-like receptor 3 antagonists for the treatment of metabolic and cardiovascular diseases
KR101683033B1 (ko) 2008-10-31 2016-12-06 얀센 바이오테크 인코포레이티드 톨-유사 수용체 3 길항제
US20100136096A1 (en) * 2008-12-02 2010-06-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Systems for modulating inflammation
US20100137246A1 (en) * 2008-12-02 2010-06-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Anti-inflammatory compositions and methods
US20100136097A1 (en) * 2008-12-02 2010-06-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Systems for modulating inflammation
US20100136095A1 (en) * 2008-12-02 2010-06-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Systems for modulating inflammation
US20100136094A1 (en) * 2008-12-02 2010-06-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Systems for modulating inflammation
US20100135908A1 (en) * 2008-12-02 2010-06-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Delivery devices for modulating inflammation
US20100135983A1 (en) * 2008-12-02 2010-06-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Anti-inflammatory compositions and methods
HUE028021T2 (en) * 2009-04-29 2016-11-28 Janssen Biotech Inc Pen-like receptor antagonists
DK2451844T3 (en) 2009-07-10 2015-07-27 Innate Pharma Tlr3-retention agents
CN102639700A (zh) 2009-09-30 2012-08-15 哈佛大学校长及研究员协会 通过调节自噬增强基因产物调节自噬的方法
US20140065154A1 (en) 2011-01-12 2014-03-06 Innate Pharma Tlr3 binding agents
LT2748201T (lt) * 2011-08-23 2018-02-26 Roche Glycart Ag Dvigubai specifinė t ląsteles aktyvinantį antigeną surišanti molekulė
WO2013026837A1 (en) * 2011-08-23 2013-02-28 Roche Glycart Ag Bispecific t cell activating antigen binding molecules
MX362457B (es) * 2011-09-12 2019-01-18 Janssen Biotech Inc Antagonistas del receptor tipo toll 3.
MX361773B (es) 2012-05-31 2018-12-17 Innate Pharma Agentes de ligación a tlr3.
TWI682941B (zh) 2013-02-01 2020-01-21 美商再生元醫藥公司 含嵌合恆定區之抗體
CN110437337B (zh) * 2013-02-26 2024-07-30 罗切格利卡特公司 双特异性t细胞活化性抗原结合分子
US9198898B2 (en) 2013-06-24 2015-12-01 Tigercat Pharma, Inc. Use of NK-1 receptor antagonists in pruritus
US8906951B1 (en) 2013-06-24 2014-12-09 Tigercat Pharma, Inc. Use of NK-1 receptor antagonists in pruritus
TWI754319B (zh) 2014-03-19 2022-02-01 美商再生元醫藥公司 用於腫瘤治療之方法及抗體組成物
ES2809455T3 (es) 2014-11-17 2021-03-04 Regeneron Pharma Métodos para tratamiento tumoral usando anticuerpo biespecífico CD3xCD20
DK3277725T3 (da) 2015-03-30 2021-01-11 Regeneron Pharma Konstante tungkædeområder med reduceret binding til FC-gammareceptorer
MY195059A (en) 2015-09-23 2023-01-05 Regeneron Pharma Optimized Anti-CD3 Bispecific Antibodies and Uses Thereof
JP7044700B2 (ja) 2015-10-02 2022-03-30 エフ・ホフマン-ラ・ロシュ・アクチェンゲゼルシャフト 二重特異性抗ceaxcd3 t細胞活性化抗原結合分子
IL313608A (en) 2015-12-09 2024-08-01 Hoffmann La Roche Antibody against CD20 type II to reduce the formation of antibodies against drugs
BR112018011029A2 (pt) 2016-01-08 2018-11-21 Hoffmann La Roche métodos para tratar ou atrasar a progressão do câncer e para melhorar a função imune em um indivíduo com câncer, usos de um antagonista de ligação e de um anticorpo biespecífico, composições e kits
US20230041197A1 (en) 2018-06-20 2023-02-09 Progenity, Inc. Treatment of a disease of the gastrointestinal tract with an immunomodulator
US12227565B2 (en) 2018-06-20 2025-02-18 Biora Therapeutics, Inc. Method of formulating a pharmaceutical composition comprising administering an immune modulator to the small intestine
ES3009025T3 (en) 2018-08-31 2025-03-25 Regeneron Pharma Dosing strategy that mitigates cytokine release syndrome for cd3/cd20 bispecific antibodies

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) * 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US5225539A (en) * 1986-03-27 1993-07-06 Medical Research Council Recombinant altered antibodies and methods of making altered antibodies
EP1988166A1 (en) 1997-05-07 2008-11-05 Schering Corporation Human Toll-like receptor proteins, related reagents and methods
US20030032090A1 (en) * 1997-05-07 2003-02-13 Schering Corporation, A New Jersey Corporation Human receptor proteins; related reagents and methods
EP1212064A2 (en) 1999-03-09 2002-06-12 Max-Delbrück-Centrum Für Molekulare Medizin Use of inhibitors of endotoxin for the treatment of heart failure and of cachexia
GB9930616D0 (en) 1999-12-24 2000-02-16 Mathilda & Terence Kennedy Ins Activation and inhibition of the immune system
EP1435987A4 (en) * 2001-09-07 2005-11-23 Univ Boston METHOD AND COMPOSITION FOR THE TREATMENT OF DISEASES RELATED TO THE IMMUNO COMPLEX
WO2003031573A2 (en) 2001-10-05 2003-04-17 Coley Pharmaceutical Gmbh Toll-like receptor 3 signaling agonists and antagonists
EP1495756A4 (en) 2002-04-08 2009-10-28 Takeda Pharmaceutical THERAPEUTIC AGENT FOR SEVERE SEPTIC STATE PREVENTION
JP2004016021A (ja) * 2002-06-12 2004-01-22 Japan Science & Technology Corp 抗体および阻害剤並びにそれを用いた形質転換方法および形質転換キット
US7410975B2 (en) * 2003-06-20 2008-08-12 Coley Pharmaceutical Group, Inc. Small molecule toll-like receptor (TLR) antagonists

Similar Documents

Publication Publication Date Title
US20250154241A1 (en) Antigen binding proteins capable of binding thymic stromal lymphopoietin
US20240010738A1 (en) Antibody molecules
KR102967396B1 (ko) Gipr 항체 및 이와 glp-1의 융합 단백질, 및 그의 약학 조성물 및 적용
CN108473568A (zh) 对TNF-α、IL-17A和IL-17F具有特异性的多特异性抗体分子
KR20220063221A (ko) Gipr 항체 및 이와 glp-1의 융합 단백질, 및 그의 약학 조성물 및 적용
US20140212426A1 (en) Toll-Like Receptor 3 Antagonists
US20140294815A1 (en) Caninised tumour necrosis factor antibodies and methods of using the same
EP4204094A1 (en) Methods and compositions to treat autoimmune diseases and cancer
KR102571012B1 (ko) 항-il-22r 항체
KR20220117307A (ko) 인간 il-13 및 il-17에 대해 결합 특이성을 갖는 다중 특이적 항체
JP2025503202A (ja) 抗インターロイキン-11抗体及びその使用
CN108368168B (zh) 结合TNFα的抗体分子
RU2800370C2 (ru) Антитело к gipr и его слитый с glp-1 белок, а также фармацевтическая композиция на его основе и его применение
WO2025049818A1 (en) Tnfr1 antagonists lacking agonist activity and uses thereof
HK1185887B (en) Improved antibody molecules
HK1145843B (en) Antigen binding proteins capable of binding thymic stromal lymphopoietin